192 related articles for article (PubMed ID: 9404422)
1. [Renal vascular responses of bradykinin in the isolated rat kidney].
Bagate K; Develioglu L; Michel B; Grima M; Imbs JL; Barthelmebs M
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1131-4. PubMed ID: 9404422
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
[TBL] [Abstract][Full Text] [Related]
3. Vascular catabolism of bradykinin in the isolated perfused rat kidney.
Bagaté K; Develioglu L; Grima M; De Jong W; Simmons WH; Imbs JL; Barthelmebs M
Eur J Pharmacol; 2000 Nov; 407(3):317-25. PubMed ID: 11068029
[TBL] [Abstract][Full Text] [Related]
4. Vascular kinin B(1) and B(2) receptor-mediated effects in the rat isolated perfused kidney - differential regulations.
Bagaté K; Develioglu L; Imbs JL; Michel B; Helwig JJ; Barthelmebs M
Br J Pharmacol; 1999 Dec; 128(8):1643-50. PubMed ID: 10588918
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin increases catecholamine release via B2 receptors.
Dendorfer A; Häuser W; Falias D; Dominiak P
Pflugers Arch; 1996; 432(3 Suppl):R99-106. PubMed ID: 8994550
[TBL] [Abstract][Full Text] [Related]
6. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
[TBL] [Abstract][Full Text] [Related]
7. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
8. Role of endothelium-derived bradykinin in the control of vascular tone.
Hecker M; Dambacher T; Busse R
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
[TBL] [Abstract][Full Text] [Related]
9. Signal transduction pathways involved in kinin B(2) receptor-mediated vasodilation in the rat isolated perfused kidney.
Bagaté K; Grima M; Imbs JL; Jong WD; Helwig JJ; Barthelmebs M
Br J Pharmacol; 2001 Apr; 132(8):1735-42. PubMed ID: 11309245
[TBL] [Abstract][Full Text] [Related]
10. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
[TBL] [Abstract][Full Text] [Related]
11. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
13. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
Miyamoto A; Murata S; Nishio A
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
[TBL] [Abstract][Full Text] [Related]
14. Vascular B1 kinin receptors in patients with congestive heart failure.
Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
[TBL] [Abstract][Full Text] [Related]
15. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors.
Auch-Schwelk W; Kuchenbuch C; Claus M; Walther B; Bossaller C; Friedel N; Graf K; Gräfe M; Fleck E
Eur Heart J; 1993 Nov; 14 Suppl I():154-60. PubMed ID: 8293767
[TBL] [Abstract][Full Text] [Related]
16. Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway.
Nowak W; Errasti AE; Armesto AR; Santín Velazque NL; Rothlin RP
Eur J Pharmacol; 2011 Sep; 667(1-3):271-7. PubMed ID: 21651905
[TBL] [Abstract][Full Text] [Related]
17. Coronary vasomotor response to the selective B1-kinin-receptor agonist Des-Arg9-bradykinin in humans.
Aptecar E; Lecorvoisier P; Teiger E; Garot P; Dupouy P; Sediame S; Vermes E; Loisance D; Hittinger L; Dubois-Rande JL; Montagne O
J Heart Lung Transplant; 2006 Feb; 25(2):187-94. PubMed ID: 16446219
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological mechanisms involved in the vasodilator effects of extracts from Echinodorus grandiflorus.
Tibiriçá E; Almeida A; Caillleaux S; Pimenta D; Kaplan MA; Lessa MA; Figueiredo MR
J Ethnopharmacol; 2007 Apr; 111(1):50-5. PubMed ID: 17150321
[TBL] [Abstract][Full Text] [Related]
19. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
[TBL] [Abstract][Full Text] [Related]
20. Involvement of bradykinin B1 and B2 receptors in relaxation of mouse isolated trachea.
Li L; Vaali K; Paakkari I; Vapaatalo H
Br J Pharmacol; 1998 Apr; 123(7):1337-42. PubMed ID: 9579728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]